AI Article Synopsis

  • Malaria parasites have a unique mitochondrial electron transport chain (ETC) critical for their growth in both humans and mosquitoes, presenting a potential target for antimalarial drugs.
  • The attachment of heme to cytochromes in these parasites relies on two separate homologs of holocytochrome synthase (HCCS), unlike humans which have a single enzyme for this process.
  • Research using CRISPR/Cas9 showed that knocking down one HCCS specifically impairs one type of cytochrome's production and disrupts ETC function, highlighting the distinct roles of these enzymes in the parasite's mitochondrial biogenesis and providing a basis for targeting the ETC in malaria treatment.

Article Abstract

malaria parasites retain an essential mitochondrional electron transport chain (ETC) that is critical for growth within humans and mosquitoes and a key antimalarial drug target. ETC function requires cytochromes and that are unusual among heme proteins due to their covalent binding to heme via conserved CXXCH sequence motifs. Heme attachment to these proteins in most eukaryotes requires the mitochondrial enzyme holocytochrome synthase (HCCS) that binds heme and the apo cytochrome to facilitate biogenesis of the mature cytochrome or . Although humans encode a single bifunctional HCCS that attaches heme to both proteins, parasites are like yeast and encode two separate HCCS homologs thought to be specific for heme attachment to cyt (HCCS) or cyt (HCCS). To test the function and specificity of HCCS and HCCS, we used CRISPR/Cas9 to tag both genes for conditional expression. HCCS knockdown selectively impaired cyt biogenesis and caused lethal ETC dysfunction that was not reversed by over-expression of HCCS. Knockdown of HCCS caused a more modest growth defect but strongly sensitized parasites to mitochondrial depolarization by proguanil, revealing key defects in ETC function. These results and prior heterologous studies in of cyt hemylation by HCCS and HCCS strongly suggest that both homologs are essential for mitochondrial ETC function and have distinct specificities for biogenesis of cyt and , respectively, in parasites. This study lays a foundation to develop novel strategies to selectively block ETC function in malaria parasites.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10862854PMC
http://dx.doi.org/10.1101/2024.02.01.575742DOI Listing

Publication Analysis

Top Keywords

malaria parasites
12
hccs
12
electron transport
8
transport chain
8
heme proteins
8
heme attachment
8
hccs homologs
8
cyt hccs
8
hccs hccs
8
hccs knockdown
8

Similar Publications

Malian field isolates provide insight into Plasmodium malariae intra-erythrocytic development and invasion.

PLoS Negl Trop Dis

January 2025

Malaria Research and Training Center (MRTC), Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.

Plasmodium malariae is the third most prevalent human malaria parasite species and contributes significantly to morbidity. Nevertheless, our comprehension of this parasite's biology remains limited, primarily due to its frequent co-infections with other species and the lack of a continuous in vitro culture system. To effectively combat and eliminate this overlooked parasite, it is imperative to acquire a better understanding of this species.

View Article and Find Full Text PDF

Human mobility and malaria risk in peri-urban and rural communities in the Peruvian Amazon.

PLoS Negl Trop Dis

January 2025

Laboratorio ICEMR- Enfermedades Emergentes, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima, Perú.

Background: While the global burden of malaria cases has decreased over the last two decades, the disease remains a major international threat, even on the rise in many regions. More than 85% of Peruvian malaria cases are in the Amazonian region of Loreto. Internal mobility primarily related to occupation is thought to be primarily responsible for maintaining endemicity and introducing and reintroducing malaria parasites into areas of anophelism, a challenge for malaria eradication.

View Article and Find Full Text PDF

Genetic diversity of and field isolates from Honduras in the malaria elimination phase.

Curr Res Parasitol Vector Borne Dis

November 2024

Instituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, 11101, Honduras.

Malaria continues to be a major threat to public health in tropical regions, primarily affecting sub-Saharan Africa but also Asia, the Middle East, and Latin America. Malaria cases in Honduras have seen a significant decline and the country aims to eliminate the disease by 2030. This study examines the genetic diversity of and in Honduras using four molecular markers (, , , and ), and the chloroquine resistance marker in the context of the elimination phase.

View Article and Find Full Text PDF

Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with and increased interleukin-12 (IL-12) and CD8α dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production.

View Article and Find Full Text PDF

Uganda started implementing mass drug administration against schistosomiasis in 2003, with district used as an implementation unit. This resulted into misclassification of communities into wrong risk levels, under-or-over treatment and over request of praziquantel (PZQ) drugs. The objective of the current study was to reviewing the community data available at World Health Organization/ESPEN database to understand the status of schistosomiasis and identify pockets with infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!